Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT01809392 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelocytic Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: decitabine

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]